A Spotlight on Health Care Disparity During COVID-19
May 5th 2020Devin English, assistant professor at Rutgers School of Health, joined Drug Topics® to discuss how COVID-19 is disproportionately affecting minorities, the history that explains this trend, and the issues that will remain after the pandemic ends.
FDA Issues Emergency Use Authorization for Remdesivir in COVID-19
May 1st 2020Officials with the FDA have issued an emergency use authorization for remdesivir (Gilead Sciences) for the treatment of suspected or laboratory-confirmed coronavirus disease 2019 (COVID-19) in hospitalized adults and children.
FDA OKs Niraparib for Frontline Maintenance Treatment of Ovarian Cancer
April 30th 2020Officials with the FDA approved niraparib (Zejula, GlaxoSmithKline), a once-daily, oral monotherapy, for the first-line maintenance treatment of platinum-responsive advanced ovarian cancer regardless of biomarker status.